Search Results - "Ferreira, Lucas Am"
-
1
Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis
Published in International journal of nanomedicine (01-01-2016)“…There is a great need for orally active drugs for the treatment of the neglected tropical disease leishmaniasis. Amphiphilic Sb(V) complexes, such as 1:3…”
Get full text
Journal Article -
2
Nanoencapsulated all- trans retinoic acid as an adjuvant for mucosal vaccines
Published in Nanomedicine (London, England) (01-06-2023)Get full text
Journal Article -
3
α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles
Published in Colloids and surfaces, B, Biointerfaces (01-04-2016)“…[Display omitted] •Preparation, optimization, and characterization of solid lipid nanoparticles (SLNs) co-encapsulated with doxorubicin and α-tocopheryl…”
Get full text
Journal Article -
4
Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis
Published in Nanomedicine (London, England) (01-08-2022)“…Amphotericin B (AmB) is an antileishmanial drug with high toxicity; however, this drawback might overcome by decreasing the AmB self-aggregation state. This…”
Get full text
Journal Article -
5
Nanostructured Lipid Carriers Enhances The Safety Profile of Tretinoin: In Vitro and Healthy Human Volunteers’ Studies
Published in Nanomedicine (London, England) (01-07-2021)Get full text
Journal Article -
6
Novel vesicular and particulate drug delivery systems for topical treatment of acne
Published in Expert opinion on drug delivery (01-06-2008)“…The efficacy of the antiacne topical drugs is well established. The local side effects, however, mainly cutaneous irritation, erythema, dryness, peeling and…”
Get more information
Journal Article -
7
Metabolomics as a tool to evaluate the toxicity of formulations containing amphotericin B, an antileishmanial drug
Published in Toxicology research (Cambridge) (01-01-2016)“…Amphotericin B (AmB) is a drug of choice against life-threatening systemic fungal infections and an alternative therapy for the treatment of all forms of…”
Get full text
Journal Article